Compare Palvella Therapeutics (PI6) vs. Competitors
0 Followers
Comparison Results
| Name | Price | Market Cap | P/E Ratio | Yearly Gain | Analyst Consensus | Analyst Price Target | Compare | Top Analysts' Price Target | Smart Score | Follow |
|---|---|---|---|---|---|---|---|---|---|---|
| DE:PI6Palvella Therapeutics | EUR 135.00 | EUR 1.96B | -33.60 | 103.01% | Strong Buy | Unlock the DE:PI6 analyst price target with TipRanks Premium | DE:PI6 | Unlock the DE:PI6 top-analyst price target with TipRanks Premium | ||
| MNPRMonopar Therapeutics Inc | $67.22 | $469.11M | -31.11 | -18.52% | Strong Buy | Unlock the MNPR analyst price target with TipRanks Premium | DE:PI6 vs MNPR | Unlock the MNPR top-analyst price target with TipRanks Premium | ||
| NRIXNurix Therapeutics | $14.84 | $2.82B | 6.35 | 19.15% | Strong Buy | Unlock the NRIX analyst price target with TipRanks Premium | DE:PI6 vs NRIX | Unlock the NRIX top-analyst price target with TipRanks Premium | ||
| TYRATyra Bioscience | $20.89 | $1.47B | -8.97 | 40.96% | Strong Buy | Unlock the TYRA analyst price target with TipRanks Premium | DE:PI6 vs TYRA | Unlock the TYRA top-analyst price target with TipRanks Premium |
Performance Comparison
| Ticker | Company Name | Price | Change | % Change | |
|---|---|---|---|---|---|
| DE:PI6 | Palvella Therapeutics | 135.00 | 69.50 | 106.11% | |
| MNPR | Monopar Therapeutics Inc | 67.22 | -13.54 | -16.77% | |
| NRIX | Nurix Therapeutics | 14.84 | 2.32 | 18.53% | |
| TYRA | Tyra Bioscience | 20.89 | 6.61 | 46.29% |
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
